Skip to main content
. 2018 May 25;53(2):672–684. doi: 10.3892/ijo.2018.4421

Figure 2.

Figure 2

Abnormal WAVE3 expression in patients with pancreatic cancer. (A) Box plots are presented to compare the expression of WAVE3 between pancreatic cancer tissues and adjacent non-cancerous tissues. (B) Differences in WAVE3 expression with different tumor differentiations. (C) Difference in WAVE3 expression between low pre-operative CA19-9 and high pre-operative CA19-9 levels in pancreatic cancer. (D) Expression of WAVE3 in pancreatic cancer cases with or without lymphatic metastasis (LM). The boxes represent 25-75% of the observations. The median is indicated by the bold lines, and the mean is indicated by the ‘+’. *P<0.05. WAVE3, Wiskott-Aldrich syndrome protein family verprolin-homologous protein 3.